Menu
The IGBA’s 5th annual Global Biosimilars Week is taking place from November 11-15, 2024. The mission of this social media campaign is to raise awareness of the powerful and lifechanging impacts of biosimilar medicines.
The theme this year is Advancing Access to Biosimilars. There have been great strides made in the approval, market acceptance and adoption of biosimilar medicines over the past two decades, but progress has been varied around the globe.
The GBMA, on behalf of their international counterparts, invite patients, healthcare professionals, government organisations and other interested parties in Australia to show their support of biosimilars throughout the week by using the hashtag #GlobalBiosimilarsWeek.
To learn more, visit the IGBA’s global site: Global Biosimilars Week
With an effort to highlight the importance of collaboration among healthcare professionals, patients, stakeholders, and policymakers, this global webinar will focus on Streamlining Regulatory Requirements to advance access to biosimilars, with expert discussions on the key barriers to biosimilar uptake in different regions and explore strategies to overcoming these obstacles.
Register to be part of this important conversation during Global Biosimilars Week and contribute to the global movement for biosimilar access.
Hear from Adrian van den Hoven, Chair of the IGBA, introducing this year’s theme:
Questions? Please reach out to the GBMA via our ‘Contact us’ page.
The information a reader is about to be referred to may not comply with the Australian regulatory requirements.
Further information relevant to the Australian environment is available from the Australian Government, Department of Health.
Please click “Continue” to leave this website and proceed to the selected site.